2019 New Patent “Salts and Polymorphs of Cethromycin for the Treatment of Disease”
AliquantumRx Inc. announces the filing of a provisional patent application No. 62/942,508 entitled “Salts and Polymorphs of Cethromycin for the treatment of disease”. “We are very excited to have discovered and patented a new salt formulation of cethromycin” said Dr. Sullivan, Chairman of the Board of AliquantumRx Inc. “Salts are easier to handle and manufacture […]